151 related articles for article (PubMed ID: 7407794)
1. Pilot studies and new agent programs of the Eastern Cooperative Oncology Group.
Bennett JM; Zelen M
Cancer Treat Rep; 1980; 64(2-3):525-32. PubMed ID: 7407794
[TBL] [Abstract][Full Text] [Related]
2. Assessment of toxicity in cooperative oncology clinical trials: the long and short of it.
Gwede CK; Johnson DJ; Daniels SS; Trotti A
J Oncol Manag; 2002; 11(2):15-21. PubMed ID: 11989815
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel doublets in metastatic breast cancer: Eastern Cooperative Oncology Group and Hoosier Oncology Group Studies.
Sledge GW
Semin Oncol; 1996 Oct; 23(5 Suppl 11):57-9. PubMed ID: 8893901
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin/paclitaxel combination chemotherapy for metastatic breast cancer: the Eastern Cooperative Oncology Group experience.
Sledge GW
Semin Oncol; 1995 Oct; 22(5 Suppl 12):123-5; discussion 126-9. PubMed ID: 7481854
[TBL] [Abstract][Full Text] [Related]
5. Radiation oncology research in the cancer and leukemia group B.
Bogart JA; Seagren SL; Glicksman A
Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3628s-34s. PubMed ID: 16740797
[TBL] [Abstract][Full Text] [Related]
6. Phase II trials: use of a clinical tumor panel and overview of current resources and studies.
Muggia FM; Rozencweig M; Chiuten DF; Jensen-Akula MS; Charles LM; Kubota TT; Bono VH
Cancer Treat Rep; 1980 Jan; 64(1):1-9. PubMed ID: 6991100
[No Abstract] [Full Text] [Related]
7. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
8. Comparisons of Cooperative Group evaluation criteria for multiple-drug therapy for breast cancer.
Davis HL; Multhauf P; Klotz J
Cancer Treat Rep; 1980; 64(2-3):507-17. PubMed ID: 7407792
[TBL] [Abstract][Full Text] [Related]
9. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Wadler S; Yeap B; Vogl S; Carbone P
Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
[TBL] [Abstract][Full Text] [Related]
10. Surgeons: A Future Role in Clinical Trials?
Rusch VW
Oncologist; 1997; 2(3):V-VI. PubMed ID: 10388050
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of toxicity: statistical considerations.
Herson J
Cancer Treat Rep; 1980; 64(2-3):463-8. PubMed ID: 7407785
[TBL] [Abstract][Full Text] [Related]
12. [Methods for clinical study of antineoplastic drugs].
Lichinitser MR
Vopr Onkol; 1986; 32(8):93-8. PubMed ID: 3765515
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of toxicity: clinical issues.
Vietti TJ
Cancer Treat Rep; 1980; 64(2-3):457-61. PubMed ID: 6996808
[TBL] [Abstract][Full Text] [Related]
14. [Phase II therapeutic trials in Cancerology: what's new? For a better multicenter and multidisciplinary cooperation].
Pignon JP
Gastroenterol Clin Biol; 1992; 16(2):131-3. PubMed ID: 1568539
[No Abstract] [Full Text] [Related]
15. Cooperative clinical of single and combined agent protocols: adjuvant protocols. National Prostatic Cancer Project Cooperative Clinical Trials.
Gibbons RP
Urology; 1981 Apr; 17(4 Suppl):48-52. PubMed ID: 7010762
[No Abstract] [Full Text] [Related]
16. [Current status and issues in clinical trials of anticancer agents].
Kojima H
Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():295-301. PubMed ID: 7986107
[TBL] [Abstract][Full Text] [Related]
17. Drug trials in pediatric oncology: a multi-facetted problem.
Boos J
Int J Clin Pharmacol Ther; 1998 Nov; 36(11):613-20. PubMed ID: 9849753
[TBL] [Abstract][Full Text] [Related]
18. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
19. [The revision of Guidelines for Clinical Evaluation Methods of Anti-Cancer Drugs in Japan].
Andoh M; Fujiwara Y; Shimada Y
Gan To Kagaku Ryoho; 2006 Jul; 33(7):1015-9. PubMed ID: 16878363
[TBL] [Abstract][Full Text] [Related]
20. The cancer and leukemia group B pharmacology and experimental therapeutics committee: a historical perspective.
Ratain MJ; Miller AA; McLeod HL; Venook AP; Egorin MJ; Schilsky RL
Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3612s-6s. PubMed ID: 16740794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
